Celltrion | 068270 - 营业利润

金融业

KRW

KRW 759.44B

现金及等价物

KRW 49.87B

KRW 107.42B

KRW 470.6B

KRW 283.62B

KRW 161.31B

股息收益率

0.41

KRW 12.08B

KRW 17.79B

1.07K

EPS每股收益

KRW 1.58K

股本和储备

KRW 435.96B

KRW 46.98B

债务利息支出

KRW 19B

KRW 621.35M

KRW 412.27B

KRW 36016.75B

KRW 8.88B

KRW 140.68B

KRW 13.72B

普通股股本

KRW 218.61M

67.83

KRW 10.5B

KRW 1150B

销售和管理费用

KRW 12.71B

KRW 122.94B

贸易债权人

KRW 78.68B

应收帐款人

KRW 2049.53B

	营业利润	更改		日
Akebia Therapeutics	USD -5.45M		9.4M	2025-12
Alaunos Therapeutics	USD -1.01M		175K	2026-03
Avita Medical	AUD -10.41M		742K	2025-12
Celltrion	KRW 13.72B		287.31B	2025-12
Dianthus Therapeutics	USD -69.54M		29.25M	2025-12
Ionis Pharmaceuticals	USD -118M		97M	2026-03
IQVIA Holdings	USD 565M		2.11B	2026-03
Moderna	USD -1.39B		531M	2026-03
Organon & Co	USD 217M		171M	2025-12
Revvity	USD 82.77M		63.06M	2026-03
Tectonic Therapeutic	USD -21.52M		374K	2025-12
Viatris	USD -20.2M		137.3M	2026-03
Xeris Pharmaceuticals	USD 16.77M		10.04M	2025-12